Blueberries Medical Corp. (BBRRF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Blueberries Medical Corp. (BBRRF) with AI Score 59/100 (Hold). Blueberries Medical Corp. is a Colombia-based company focused on the cultivation, production, and supply of medicinal cannabis. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Blueberries Medical Corp. (BBRRF) Healthcare & Pipeline Overview
Blueberries Medical Corp. cultivates, develops, and supplies medicinal cannabis products in Colombia, targeting the growing Latin American market. The company offers medicinal-grade cannabis oil extracts, but faces challenges related to profitability and regulatory landscapes in the evolving cannabis industry. It trades on the OTC market.
Investment Thesis
Blueberries Medical Corp. presents a high-risk, high-reward investment opportunity within the emerging Latin American cannabis market. The company's focus on medicinal-grade cannabis oil extracts positions it to capitalize on the growing demand for alternative therapies. However, the company's negative profit margin of -375.4% and OTC listing indicate significant financial and operational challenges. Growth catalysts include expanding distribution networks and securing regulatory approvals in new markets. Key risks include intense competition, evolving regulations, and the company's ability to achieve profitability. Investors should carefully consider the company's financial position, market dynamics, and regulatory environment before investing.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $0.01B reflects the company's small size and speculative nature.
- P/E Ratio of -3.19 indicates the company is currently not profitable.
- Gross Margin of 31.0% suggests potential for profitability if operating expenses are managed effectively.
- Beta of 2.65 indicates high volatility compared to the overall market.
- The company does not currently pay a dividend, reflecting its focus on reinvesting earnings for growth.
Competitors & Peers
Strengths
- Presence in the emerging Latin American cannabis market.
- Focus on medicinal-grade cannabis oil extracts.
- Vertically integrated operations from cultivation to production.
- Experienced management team with expertise in cannabis cultivation and extraction.
Weaknesses
- Negative profit margin and limited financial resources.
- Dependence on regulatory approvals and market access.
- Intense competition from established cannabis producers.
- OTC listing indicates higher risk and lower liquidity.
Catalysts
- Ongoing: Expansion into new Latin American markets, driving revenue growth.
- Ongoing: Development of new cannabis-based products targeting specific medical conditions.
- Ongoing: Strategic partnerships with healthcare providers to promote the use of medicinal cannabis products.
- Upcoming: Securing regulatory approvals in key markets, such as Colombia and other Latin American countries.
- Ongoing: Improving production efficiency and reducing costs through investments in technology and process optimization.
Risks
- Ongoing: Evolving regulations and uncertainty in the cannabis industry.
- Potential: Price competition from low-cost producers.
- Potential: Potential for oversupply in the cannabis market.
- Potential: Negative public perception of cannabis.
- Ongoing: Limited financial resources and negative profit margin.
Growth Opportunities
- Expansion into New Latin American Markets: Blueberries Medical can pursue growth by expanding its operations into other Latin American countries with favorable cannabis regulations. The Latin American cannabis market is projected to experience significant growth in the coming years, offering substantial opportunities for companies with a strong regional presence. Timeline: Ongoing, with potential for significant expansion within the next 3-5 years.
- Development of New Cannabis-Based Products: Blueberries Medical can invest in research and development to create new cannabis-based products targeting specific medical conditions. This could include formulations for pain management, anxiety, and sleep disorders. The market for specialized cannabis products is growing rapidly, driven by increasing demand for alternative therapies. Timeline: Ongoing, with new product launches expected within the next 1-2 years.
- Strategic Partnerships with Healthcare Providers: Blueberries Medical can establish strategic partnerships with healthcare providers to promote the use of its medicinal cannabis products. This could involve educating doctors and other healthcare professionals about the benefits of cannabis-based treatments. The healthcare provider channel represents a significant opportunity for reaching patients and increasing sales. Timeline: Ongoing, with partnerships expected to expand within the next 1-3 years.
- Securing Regulatory Approvals in Key Markets: Blueberries Medical can focus on securing regulatory approvals for its products in key markets, such as Colombia and other Latin American countries. Regulatory approvals are essential for accessing these markets and establishing a competitive advantage. Timeline: Ongoing, with approvals expected to be secured within the next 1-2 years.
- Improving Production Efficiency and Reducing Costs: Blueberries Medical can improve its production efficiency and reduce costs through investments in technology and process optimization. This would improve the company's profitability and competitiveness. The cannabis industry is becoming increasingly competitive, making cost efficiency a critical success factor. Timeline: Ongoing, with continuous improvements expected over the next several years.
Opportunities
- Expansion into new Latin American markets.
- Development of new cannabis-based products.
- Strategic partnerships with healthcare providers.
- Increasing acceptance of medicinal cannabis globally.
Threats
- Evolving regulations and uncertainty in the cannabis industry.
- Price competition from low-cost producers.
- Potential for oversupply in the cannabis market.
- Negative public perception of cannabis.
Competitive Advantages
- First-mover advantage in the Colombian medicinal cannabis market.
- Proprietary cultivation and extraction techniques.
- Established relationships with healthcare providers and pharmacies.
- Brand recognition in the Latin American market.
About BBRRF
Blueberries Medical Corp., headquartered in Bogotá, Colombia, is a medicinal cannabis company focused on the growth, cultivation, development, production, and supply of medicinal cannabis and related products. The company aims to capitalize on the burgeoning medicinal cannabis market in Latin America, particularly in Colombia, where regulations have created opportunities for licensed producers. Blueberries Medical offers medicinal-grade cannabis oil extracts and related products, targeting patients and healthcare providers seeking alternative treatment options. The company's operations encompass the entire value chain, from cultivation to extraction and product formulation. Blueberries Medical aims to establish a strong presence in the Colombian market and expand its reach to other Latin American countries as regulations evolve. The company faces competition from both local and international cannabis producers, as well as challenges related to regulatory compliance, market access, and pricing pressures. Blueberries Medical trades on the OTC market under the ticker symbol BBRRF.
What They Do
- Cultivates medicinal cannabis plants in Colombia.
- Develops medicinal-grade cannabis oil extracts.
- Produces a range of cannabis-related products.
- Supplies medicinal cannabis products to patients and healthcare providers.
- Focuses on the Latin American market.
- Operates throughout the entire cannabis value chain, from cultivation to product formulation.
Business Model
- Cultivation and production of medicinal cannabis.
- Sales of cannabis oil extracts and related products.
- Distribution through pharmacies and healthcare providers.
- Revenue generation through product sales in the Colombian and Latin American markets.
Industry Context
Blueberries Medical Corp. operates in the rapidly evolving medicinal cannabis industry, which is experiencing significant growth and regulatory changes. The global cannabis market is projected to reach billions of dollars in the coming years, driven by increasing acceptance of cannabis for medical and recreational purposes. The competitive landscape includes established pharmaceutical companies, specialized cannabis producers, and emerging startups. Blueberries Medical is positioned within the Latin American market, which offers unique opportunities and challenges due to varying regulatory frameworks and market dynamics. Competitors include AVTBF (Avanti Health Technologies Inc.), CANN (Cronos Group Inc.), CPIVF (Canopy Pacific Inc.), IONKF (Isracann Biosciences Inc.), and MVMDF (MediPharm Labs Corp.).
Key Customers
- Patients seeking alternative treatments for various medical conditions.
- Healthcare providers recommending or prescribing medicinal cannabis.
- Pharmacies and dispensaries selling cannabis products.
- Research institutions conducting studies on medicinal cannabis.
Financials
Chart & Info
Blueberries Medical Corp. (BBRRF) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
-
Stocks That Hit 52-Week Highs On Tuesday
· Mar 24, 2020
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BBRRF.
Price Targets
Wall Street price target analysis for BBRRF.
MoonshotScore
What does this score mean?
The MoonshotScore rates BBRRF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Facundo Garreton
CEO
Facundo Garreton is the CEO of Blueberries Medical Corp. His background includes experience in the pharmaceutical and agricultural industries. He has a proven track record of leading and growing companies in emerging markets. Garreton's expertise in regulatory affairs and market access is crucial for navigating the complex cannabis industry landscape. He holds a degree in Business Administration from a leading university.
Track Record: Under Facundo Garreton's leadership, Blueberries Medical Corp. has expanded its operations in Colombia and developed a portfolio of medicinal cannabis products. He has focused on securing regulatory approvals and establishing partnerships with healthcare providers. Garreton has also overseen the company's efforts to improve production efficiency and reduce costs.
BBRRF OTC Market Information
The OTC Other tier, where Blueberries Medical Corp. trades, represents the lowest tier of the OTC market. Companies in this tier often have limited financial disclosure, do not meet minimum listing standards, and may be subject to greater risks of fraud or manipulation compared to companies listed on major exchanges like the NYSE or NASDAQ. These companies may not be required to file reports with the SEC, leading to less transparency for investors. Investing in OTC Other stocks requires a higher degree of due diligence and risk tolerance.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Higher risk of fraud or manipulation.
- Lower trading volumes and liquidity.
- Greater price volatility.
- Potential for delisting or suspension of trading.
- Verify the company's financial statements and audit reports.
- Research the background and experience of the management team.
- Assess the company's regulatory compliance and legal standing.
- Evaluate the company's competitive position and market outlook.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Confirm the legitimacy of the company's operations and assets.
- Licensed to cultivate and produce medicinal cannabis in Colombia.
- Partnerships with healthcare providers and pharmacies.
- Presence in the Latin American market.
- Experienced management team with expertise in the cannabis industry.
BBRRF Healthcare Stock FAQ
What does Blueberries Medical Corp. do?
Blueberries Medical Corp. is a Colombia-based company focused on the cultivation, production, and supply of medicinal cannabis and related products. The company aims to capitalize on the growing demand for alternative therapies by offering medicinal-grade cannabis oil extracts. Its operations encompass the entire value chain, from cultivation to extraction and product formulation. Blueberries Medical targets patients and healthcare providers seeking alternative treatment options in the Latin American market. The company faces competition from both local and international cannabis producers.
What do analysts say about BBRRF stock?
As an OTC-listed company with a small market capitalization, Blueberries Medical Corp. (BBRRF) may not be widely covered by analysts. Given the company's negative profit margin and volatile industry, any analyst coverage is likely to emphasize the high-risk, high-reward nature of the investment. Investors should conduct their own due diligence and carefully consider the company's financial position, market dynamics, and regulatory environment. Analyst reports, if available, should be viewed as one data point among many in a comprehensive investment analysis.
What are the main risks for BBRRF?
The main risks for Blueberries Medical Corp. include evolving regulations in the cannabis industry, intense competition from established producers, and the potential for oversupply in the market. The company's negative profit margin and limited financial resources also pose significant challenges. As an OTC-listed company, BBRRF is subject to greater risks of fraud, manipulation, and illiquidity. Investors should carefully consider these risks before investing in Blueberries Medical Corp.
What are the key factors to evaluate for BBRRF?
Blueberries Medical Corp. (BBRRF) currently holds an AI score of 59/100, indicating moderate score. Key strength: Presence in the emerging Latin American cannabis market.. Primary risk to monitor: Ongoing: Evolving regulations and uncertainty in the cannabis industry.. This is not financial advice.
How frequently does BBRRF data refresh on this page?
BBRRF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven BBRRF's recent stock price performance?
Recent price movement in Blueberries Medical Corp. (BBRRF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Presence in the emerging Latin American cannabis market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider BBRRF overvalued or undervalued right now?
Determining whether Blueberries Medical Corp. (BBRRF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying BBRRF?
Before investing in Blueberries Medical Corp. (BBRRF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available company filings and news sources.
- OTC market data may be less reliable than major exchange data.
- AI analysis pending for BBRRF.